Shingles Vaccine Safety and Effectiveness in Glioblastoma Patients
Part of Cancer clinical trials.
This study tests whether a shingles (zoster) vaccine is safe and effective for people with glioblastoma (a serious brain cancer) who are receiving radiation therapy. The vaccine might help protect patients from developing shingles while they undergo cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with glioblastoma confirmed by biopsy or pathology
- Scheduled to receive radiation therapy for your glioblastoma
- Expected to live at least 3 months
- If able to become pregnant, willing to use reliable birth control during the study
- Able to understand and sign informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a chemotherapy drug called thiotepa into the fluid around the brain and spine can prevent glioblastoma from spreading in patients whose tumor touches the fluid-filled spaces or who had a leak during surgery.
This trial tests whether a more focused, stronger dose of radiation can improve outcomes for people 65 and older with newly diagnosed glioblastoma. It compares this approach to standard radiation to see if it's safe and effective.
This trial combines a new therapy (sonodynamic therapy) with standard radiation and chemotherapy for glioblastoma. It aims to see if this approach is safe and how well it works for people who have just been diagnosed and had surgery.
This study tests a combination treatment for glioblastoma, a type of brain cancer. It includes a personalized vaccine made from your tumor, along with chemotherapy and an immunotherapy drug (anti-PD-1). The goal is to see if this combination helps people with this cancer.
This trial is testing whether a drug called G-CSF (which helps boost white blood cells) can help people with glioblastoma who are already receiving standard treatment with radiation and chemotherapy (temozolomide). It aims to see if G-CSF can reduce side effects and improve outcomes.
This trial tests an experimental vaccine for glioblastoma, given after the usual radiation and chemotherapy (temozolomide). The goal is to see if the vaccine helps the immune system fight remaining cancer cells.
Hear when a new Glioblastoma (GBM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.